Latest News

Latest News2018-07-31T19:14:53+01:00

Dublin-based Bounce Insights raises €4.2 million to expand its AI-powered market research platform into the US

December 12th, 2024|

Bounce Insights, an Irish startup specialising in AI-powered market research, has announced a €4.2 million funding round. This funding will fuel the company’s expansion into the US market, including the opening of a New York office to support its 25-person team and plans to triple its headcount globally by the end of 2026. Read more

AnaBio and Milky Mist India announce the launch of the first long-life dairy drink fortified with Anabio encapsulated probiotics.

December 12th, 2024|

South Indian dairy company MilkyMist has teamed up with SIG and AnaBio Technologies to introduce what is claimed to be the world’s first long-life probiotic buttermilk in aseptic carton packs. The ground-breaking development, showcased at Gulfood Manufacturing 2024 in Dubai, represents a major breakthrough in the beverage industry, allowing probiotics to be incorporated into shelf-stable drinks in aseptic cartons for the first time. Read Article Here [...]

First marketing approval in China for Cinclus Pharma

December 12th, 2024|

Swedish clinical-stage drug developer Cinclus Pharma (STO: CINPHA), a specialist in treatments for gastric acid-related diseases, had picked up Chinese approval for linaprazan glurate. The outcome represents the firm’s first marketing approval in China. The approval by the National Medical Products Administration (NMPA) paves the way for commercialization in the People’s Republic of China in 2025. Read Article Here

SymPhysis Medical secures €2.2m funding for cancer patient device

October 10th, 2024|

Galway MedTech company SymPhysis Medical has secured €2.2m funding for the development of a device to address the condition of fluid in the chest of cancer patients. The medtech company will seek regulatory approval in the US for its device treating end-of-life cancer patients at the end of 2025. Business Post Article

Signum Surgical’s BioHealx technology obtains FDA clearance

July 10th, 2024|

Signum Surgical, a medical technology company developing innovative solutions to treat colorectal diseases, is pleased to announce that its BioHealxTM technology has been granted marketing clearance by the U.S. Food and Drug Administration (FDA), as a first-of-its-kind medical device for the treatment of anal fistula. Read Press Release here

CroíValve wins FDA IDE for tricuspid heart valve

February 7th, 2024|

CroíValve announced today that it began an early feasibility study for its Duo tricuspid coaptation valve system. The beginning of the study follows FDA investigational device (IDE) approval. Read Full Article

If you are interested in becoming an Investor or seeking investment, then please contact us.

Go to Top